# Transforming long-term post-acute care for the aging population through home infusion therapy in China: assurance for quality and safety of care delivery (Part 2)

**Authors:** Wei Zuo, Zi Yin Zhou, Kayla Huynh, Dylan H. Do, Dan Mei, Tu Tran, Jianchun Yu, Hong Yang, Wei Chen, Bin Zhao, Vivian W. Y. Lee, Fan Zhang, Shaohong Wang, Shan Li, Austin-Phong Nguyen, Connie Vo, Huijie Shi, Jennifer Le

PMC · DOI: 10.3389/fpubh.2026.1761870 · Frontiers in Public Health · 2026-03-04

## TL;DR

Home infusion therapy combined with home health services could improve long-term care for China's aging population by providing safe, cost-effective care at home.

## Contribution

The paper recommends implementing home infusion therapy in China, emphasizing accreditation systems and professional training to ensure quality and safety.

## Key findings

- Home infusion therapy is not yet adopted in China but has been successfully used in Western countries for decades.
- Implementing home infusion therapy requires sterile standards, technological integration, and professional training.
- Home-based care can reduce hospital burden and improve patient comfort and dignity.

## Abstract

China's healthcare system may benefit from the integration of home infusion therapy (HIT) combined with home health services (HHS) to address the urgent need for a sustainable long-term, post-acute care model for the aging population and those with chronic complex diseases. In this Part 2, we presented the current landscape of home- and community-based care models in China and formulated recommendations for successful implementation of HIT and HHS.

We conducted a literature search up to October 2025 using MEDLINE, EMBASE, PubMed, Web of Science, and China National Knowledge Infrastructure.

To address the urgent need to support aging at home, China has initiated home- and community-based services nationwide. Despite these services, including a pilot of hospital-at-home, utilization remains low due to limited facilities, suboptimal service quality, and inadequate promotion. Notably, HIT and HHS that provide outpatient parenteral antibiotic therapy and total parenteral nutrition at home, and chemotherapy at infusion centers have not been adopted in China; yet this value-based modality has existed in western countries (including the United States, the United Kingdom, Australia, Canada, France, among others) for decades to provide patient-centric care that is safe and cost-effective. Implementing HIT requires a robust accreditation system, sterile compounding standards, technological integration, and professional training to ensure patient safety and quality of care.

The shift of care from hospitals to homes through HIT supported by HHS holds great potential to alleviate healthcare costs, reduce hospital burden, and enhance patient comfort and dignity in China.

Part 1 is available at https://doi.org/10.3389/fpubh.2026.1761871.

## Full-text entities

- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12997790/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12997790/full.md

## References

75 references — full list in the complete paper: https://tomesphere.com/paper/PMC12997790/full.md

---
Source: https://tomesphere.com/paper/PMC12997790